Zacks Research Issues Negative Estimate for Danaher Earnings

Danaher Co. (NYSE:DHR) – Stock analysts at Zacks Research reduced their Q1 2025 earnings per share estimates for shares of Danaher in a report issued on Wednesday, February 19th. Zacks Research analyst R. Department now anticipates that the conglomerate will post earnings per share of $1.62 for the quarter, down from their prior estimate of $2.00. The consensus estimate for Danaher’s current full-year earnings is $7.63 per share. Zacks Research also issued estimates for Danaher’s Q4 2025 earnings at $2.36 EPS.

Other research analysts also recently issued reports about the company. Guggenheim began coverage on Danaher in a research note on Thursday, December 19th. They set a “buy” rating and a $275.00 target price on the stock. Citigroup dropped their target price on Danaher from $285.00 to $265.00 and set a “buy” rating on the stock in a research note on Thursday, January 30th. Royal Bank of Canada restated an “outperform” rating and set a $277.00 target price (down from $299.00) on shares of Danaher in a research note on Thursday, January 30th. Scotiabank assumed coverage on Danaher in a research report on Monday, December 23rd. They set a “sector perform” rating and a $265.00 price target for the company. Finally, Barclays lowered their price target on Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a research report on Thursday, January 30th. Seven investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $278.00.

Danaher Trading Up 0.5 %

Shares of NYSE:DHR opened at $211.23 on Monday. Danaher has a 12-month low of $196.80 and a 12-month high of $281.70. The business’s fifty day simple moving average is $226.25 and its 200-day simple moving average is $246.44. The company has a market capitalization of $150.97 billion, a PE ratio of 40.01, a P/E/G ratio of 2.66 and a beta of 0.83. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR) last issued its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter last year, the firm posted $2.09 earnings per share.

Danaher Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a dividend of $0.32 per share. This is a positive change from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a yield of 0.61%. Danaher’s dividend payout ratio is 24.24%.

Insider Buying and Selling

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the sale, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 11.10% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in DHR. Heck Capital Advisors LLC acquired a new position in Danaher in the 4th quarter worth approximately $27,000. Decker Retirement Planning Inc. acquired a new position in Danaher in the 4th quarter worth approximately $31,000. Golden State Wealth Management LLC acquired a new position in Danaher in the 4th quarter worth approximately $31,000. Teachers Insurance & Annuity Association of America acquired a new position in Danaher in the 3rd quarter worth approximately $39,000. Finally, Hurley Capital LLC acquired a new position in Danaher in the 4th quarter worth approximately $34,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.